VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection

Podobne zapisy

• VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
  od: Midgley, R, i wsp.
  Wydane: (2008)
• Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
  od: Midgley, R, i wsp.
  Wydane: (2010)
• Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
  od: Kerr, D, i wsp.
  Wydane: (2007)
• The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
  od: Huijbers, A, i wsp.
  Wydane: (2013)
• Rofecoxib Induced Purpura
  od: Dogra Sunil, i wsp.
  Wydane: (2004-01-01)